Zhejiang Orient Gene Biotech Co., Ltd.
Shanghai Stock Exchange 688298.SS
Zhejiang Orient Gene Biotech Co., Ltd. Price to Sales Ratio (P/S) on January 14, 2025: 6.85
-
Zhejiang Orient Gene Biotech Co., Ltd. 52-week high Price to Sales Ratio (P/S) is 9.89 on October 08, 2024, which is 44.47% above the current Price to Sales Ratio (P/S).
-
Zhejiang Orient Gene Biotech Co., Ltd. 52-week low Price to Sales Ratio (P/S) is 6.26 on July 09, 2024, which is -8.62% below the current Price to Sales Ratio (P/S).
-
Zhejiang Orient Gene Biotech Co., Ltd. average Price to Sales Ratio (P/S) for the last 52 weeks is 7.51.
| Date | Price to Sales Ratio (P/S) | Price to Book Ratio (P/B) | Dividend Yield | Free Cash Flow Yield |
|---|
| CEO | Mr. Xiaoliang Fang |
| IPO Date | Feb. 5, 2020 |
| Location | China |
| Headquarters | 3787#, East Yangguang Avenue |
| Employees | 2,231 |
| Sector | Health Care |
| Industries | |
Zhejiang Orient Gene Biotech Co., Ltd. researches and develops, produces, and sells colloidal gold tests, urinalysis strips, raw materials, instruments, and molecular diagnosis products primarily in China. Its products include genetic diagnosis products; colloidal gold rapid diagnostic tests for drugs of abuse, infectious diseases, fertility, cardiac and tumor markers, and autoimmunity; dry chemical strips; bio-liquid diagnostic kits; clinical test instruments; POCT time-resolved fluor immunoassay test kits; raw materials; etc. The company also exports its products to North and South America, Europe, South Asia, Southeast Asia, the Middle East, Africa, Russia, and Australia. Zhejiang Orient Gene Biotech Co., Ltd. was founded in 2005 and is based in Huzhou, China.
Past 5 years
USD 3.37
USD 0.79
USD 2.80
USD 9.57
StockViz Staff
January 15, 2025
Any question? Send us an email